期刊
ELIFE
卷 5, 期 -, 页码 -出版社
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.12735
关键词
-
类别
资金
- Wellcome Trust [WT103767MA]
- Biotechnology and Biological Sciences Research Council [BB/J004324/1]
- Oxford Martin School, University of Oxford [WT091663MA]
- Medical Research Council [MR/K000276/1]
- BBSRC [BBS/E/D/20241866, BBS/E/D/20241864] Funding Source: UKRI
- MRC [MR/K000276/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, BBS/E/D/20241866] Funding Source: researchfish
- Medical Research Council [MR/K000276/1] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0510-10204] Funding Source: researchfish
- Wellcome Trust [109965/Z/15/Z] Funding Source: researchfish
Previously, we demonstrated that frequencies of CpG and UpA dinucleotides profoundly influence the replication ability of echovirus 7 (Tulloch et al., 2014). Here, we show that that influenza A virus (IAV) with maximised frequencies of these dinucleotides in segment 5 showed comparable attenuation in cell culture compared to unmodified virus and a permuted control (CDLR). Attenuation was also manifested in vivo, with 10-100 fold reduced viral loads in lungs of mice infected with 200PFU of CpG-high and UpA-high mutants. However, both induced powerful inflammatory cytokine and adaptive (T cell and neutralising antibody) responses disproportionate to their replication. CpG-high infected mice also showed markedly reduced clinical severity, minimal weight loss and reduced immmunopathology in lung, yet sterilising immunity to lethal dose WT challenge was achieved after low dose (20PFU) pre-immunisation with this mutant. Increasing CpG dinucleotide frequencies represents a generic and potentially highly effective method for generating safe, highly immunoreactive vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据